MedTrace Logo

To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH)

NCT02923895 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 197

Last updated 2018-10-29

Study results available
· View outcomes & findings →

Summary

This single centre study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use compared with a standard fluoride dentifrice.

Conditions

  • Dentin Sensitivity

Interventions

OTHER

Stannous fluoride

0.454% weight by weight (w/w) stannous fluoride containing 1100 parts per million (ppm) fluoride

OTHER

Sodium monofluorophosphate

0.76% w/w sodium monofluorophosphate containing 1000 ppm fluoride

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-11
Primary Completion
2016-12-16
Completion
2016-12-16

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02923895 on ClinicalTrials.gov